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Abstract
Aims/Background-This study was undertaken to confirm the association between diffuse retinal pigment epitheliopathy (DRPE) and systemic corticosteroid therapy. This finding can be of help in determining an aetiological factor in DRPE and associated diseases. Corti (Table 2) .
The ages of the transplanted patients varied from 32 to 52 years (mean 40 years), those of the patients with systemic disorders from 37 to 68 years (mean 52 years) (see Table 3 Table 2 ). Visual acuity decreased during an episode with exacerbation, while the daily prednisone dosage was increased. Table 2 ) of the same patient as in Figure 4 . When the daily prednisone dosage was decreased there was fluorographically less leakage of fluorescein in both eyes, while the visual symptoms ameliorated. retinopathy seem also to be genetically related, since in one family one brother had a DRPE, one sister had a typical central serous chorioretinopathy and the other brother had DRPE in one eye with recurrent central serous chorioretinopathy in the other eye.2 Furthermore, central serous chorioretinopathy has also been described in a pair of identical twins. '6 Until now several authors have suggested that corticosteroids can damage the retinal pigment epithelial barrier and predispose a patient to serous retinal detachment, but convincing evidence that any of these drugs directly contributes to the development of central serous chorioretinopathy and associated diseases was lacking so far. 3 17 18 Psychological stress may have played a key role in the development of a DRPE or chronic central serous chorioretinopathy in our patients, but the simultaneous administration of prednisone may certainly have influenced the final visual outcome, especially since the ophthalmic symptoms decreased in some patients when the daily prednisone dosage was diminished.
Each of our transplanted patients -except one -also used other immunosuppressive agents such as azothioprine and cyclosporin, whereas some other drugs were used as well by the other patients treated for systemic disorders. None of these drugs, however, is known so far to be involved in the development of chorioretinal changes.
The findings in our patients differ from the leopard-like geographical areas of disruption and coarse clumping of the pigment epithelium in the posterior fundi, observed in some posttransplant patients.19 Localised choroidal intravascular coagulation is the suspected but unproved cause of the pigment epithelial changes in those patients. However, choroidal vascular changes have been described before in haemodialysis and kidney transplantation patients, which changes may promote the development of pigment epithelium defects.'920 Pigment epithelial alterations are seen in some patients with hypertension, and the fact that 12 of our patients were hypertensive might have promoted the development of a DRPE or chronic central serous retinopathy. In these 12 patients the use of corticosteroids also may have worsened their hypertension, so the pigment epithelial alterations in these patients can be directly as well as indirectly attributed to the corticosteroid treatment.
Both ,B blocking agents propranolol and atenolol modify type A behaviour, and the use of these drugs has been mentioned as a useful therapy in patients with a central serous chorioretinopathy.15 Five of the 12 patients who were treated with antihypertensives did actually get betalytic agents as well as corticosteroids when they developed a DRPE or chronic central serous chorioretinopathy (Tables 1 and 2 ). In many diseases the steroid treatment may be life saving and the possible susceptibility of the patient to central serous chorioretinopathy does not represent a contraindication for therapy.
Corticosteroid therapy has been widely used for the treatment of central serous chorioretinopathy and associated disorders. The findings in our patients in contrast make clear that caution should be exercised when corticosteroids are used in certain patients susceptible to develop these diseases: corticosteroids may give rise to symptoms of DRPE or chronic central serous chorioretinopathy instead of diminishing them, whereas recovery may occur when the daily dosage is lowered.
